SWITCH, trial summary    PDF trial summary

A randomised clinical trial investigating the effect of sunitinib versus sorafenib in


NCT00732914    Med Oncol 2012;29:1908-13  

Studied treatment
Control treatment

Group sizes-9 / -9
treatment line
cross over

Blindness Inclusion period
Follow-up duration Centers
Lost to FU geographical localisation
Primary endpoint Design

EndpointX1N1X0N0TE95% CI OS - -9 - -9 no data PFS - -9 - -9 no data0,22,01,0

Calvani N, Morelli F, Leo S, Orlando L, Lombardi L, Gnoni A, Cinefra M, Maiello E, Lorusso V, Cinieri S Sequential use of sorafenib and sunitinib in advanced renal cell carcinoma: does the order of sequencing matter? Med Oncol 2012;29:1908-13     [PMID: 21858552]   link to pdf   add to Mendeley  

ClinicalTrial.gov record NCT00732914

Registering number NCT00732914 (see trial on clinicaltrials.gov)
Code Name